Thursday, January 19, 2017
Adamis Pharmaceuticals Announces FDA Acceptance of Resubmission of Its Epinephrine Pre-Filled Syringe NDA
More EpiPen Rivals coming. Adamis Announces FDA Acceptance of Resubmission of Its Epinephrine Pre-Filled Syringe NDA #breakingnews #breaking #news #trending #new #happening #now http://ift.tt/2k7wr1R
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment